Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Discovery could lead to improved stem cell therapy
Whilst the human endometrium is known to harbour stem cells, this is the first time they have been obtained from the equine uterus.
Stem cells harvested from equine uterus for the first time

A new discovery could reduce pain and stress in horses undergoing stem cell therapy, according to a team of scientists who managed to harvest stem cells from the equine uterus for the first time.

Stem cells are used therapeutically in horses with tendon and joint injuries, but they are usually obtained surgically from bone marrow or fat tissue. However, stem cells can be taken from the uterus, without the need for surgical intervention, using small instruments inserted via the cervix.

Scientists from Vetmeduni Vienna collected uterine tissue samples from six mares. Suspected stem cells were separated from the endometrial epithelial cells and expanded in cell culture. Various molecular biology techniques were then used to identify potential stem cells.

The cells clearly expressed the same markers as bone marrow stem cells, according to the research team. They were also able to show that the endometrial stem cells differentiated into fat, bone, cartilage and muscle cell lines.

Whilst the human endometrium is known to harbour stem cells, this is the first time they have been obtained from the equine uterus.

“The endometrium provides a source of mesenchymal stem cells that can be easily accessed with little stress to the animals,” said senior researcher Christine Aurich.

“The cell culture results show that these cells can be of benefit not only in the treatment of uterine conditions, but that they can also replace the need for surgically obtained stem cells for therapeutic purposes in other tissue types.”

The full results have been published in the journal Stem Cell Research and Therapy.

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'